INVITROGEN CORP
10-Q, EX-27.1, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: INVITROGEN CORP, 10-Q, 2000-08-11
Next: IGO CORP, 10-Q, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM INVITROGEN'S
QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                         175,781                  36,230
<SECURITIES>                                    98,060                   2,439
<RECEIVABLES>                                   14,779                  11,681
<ALLOWANCES>                                       829                     350
<INVENTORY>                                      8,229                   7,052
<CURRENT-ASSETS>                               308,968                  60,308
<PP&E>                                          41,792                  31,442
<DEPRECIATION>                                  15,961                  12,120
<TOTAL-ASSETS>                                 346,431                  84,275
<CURRENT-LIABILITIES>                           15,445                  15,290
<BONDS>                                        172,500                       0
                                0                       0
                                          0                       0
<COMMON>                                           237                     194
<OTHER-SE>                                     155,467                  60,820
<TOTAL-LIABILITY-AND-EQUITY>                   346,431                  84,275
<SALES>                                         53,950                  44,376
<TOTAL-REVENUES>                                54,983                  45,243
<CGS>                                           17,985                  16,501
<TOTAL-COSTS>                                   17,985                  16,501
<OTHER-EXPENSES>                                31,306                  22,050
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               3,685                     377
<INCOME-PRETAX>                                  8,157                   6,780
<INCOME-TAX>                                     5,199                   2,509
<INCOME-CONTINUING>                              2,958                   4,271
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     2,958                   4,271
<EPS-BASIC>                                       0.13                    0.28
<EPS-DILUTED>                                     0.12                    0.24


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission